Jon Asplund is a journalist specializing in local business news, with a focus on the Chicago area. He is a writer for Crain's Chicago Business and his work has also been featured in Crain's Cleveland Business. Jon covers a range of topics including healthcare, business trends, and local economic developments.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Chicago, United States (Local)
Not enough data
Jon Asplund's reporting mainly focuses on the healthcare and pharmaceutical industry with a local (United States, Illinois, Chicago) perspective. His articles often cite data and government announcements as well as press releases.
When reaching out to Jon, consider providing insights or commentary on local healthcare policies, advancements in medical research from institutions in the specified geographic areas, or developments within the pharmaceutical industry that have direct relevance to his coverage area. Additionally, he may be interested in interviews with experts who can shed light on new healthcare technologies being adopted by hospitals and clinics within these regions.
It is important to tailor pitches according to the specific focus of his coverage area while also highlighting any relevant statistical data or government announcements related to healthcare topics.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Jon Asplund
Tempus and Northwestern Medicine will collaborate on ways to use artificial intelligence in clinical care, starting with patients of the Bluhm Cardiovascular Institute.
By: Jon Asplund
Health Fitness, which provides corporate fitness, wellness and injury prevention programs, has acquired Corporate Fitness Works, the third wellness acquisition by the Trustmark company since 2021.
Tempus AI announced today it is acquiring genetic testing and laboratory service provider Ambry Genetics in a $600 million deal that the Chicago-based
Tempus AI announced today it is acquiring genetic testing and laboratory service provider Ambry Genetics in a $600 million deal that the Chicago-based
By: Jon Asplund
Two Chicago health centers and a downstate hospital system are learning how to be both provider and payor to mostly dual-eligible elderly patients through PACE.
By: Jon Asplund
The University of Illinois Chicago will study the public health implications of climate change and look at nature-based intervention at a new research center backed by the federal government.
By: Jon Asplund
Chicago is ground zero in a couple of developments in the treatment of Type 1 diabetes and in the debate about how the decades-old treatment has progressed.
Xeris Biopharma Holdings raised its revenue guidance this morning on the strength of sales growth of two of its three drugs on the market and confidence in moving another drug candidate into Phase 3 testing.
UChicago Medicine is bringing back a former executive to replace Chief Equity Officer Brenda Battle as she retires at the end of the year.
By: Jon Asplund
As St. Anthony Hospital's emergency room staffing contract was set to expire earlier this year, leadership at the Southwest Side safety net had a
(833) 317-6278 
